Methylphenidate Inhibits the Development of Myopia by Altering Dopamine and Norepinephrine Reuptake
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.12.52 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Cindy Karouta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Science, Faculty of Science and Technology, University of Canberra, Bruce, Canberra, Australian Capital Territory, Australia. Hauptthemen laut MEDLINE: Myopia, Dopamine, Methylphenidate, Norepinephrine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biomedical Science, Faculty of Science and Technology, University of Canberra, Bruce, Canberra, Australian Capital Territory, Australia.
- Research School of Biology, Australian National University, Australian Capital Territory, Australia.
- John Curtin School of Medical Research, The Australian National University, Australian Capital Territory, Australia.
Zitieren
APA
Karouta, C., Thomson, K., Morgan, I., Booth, L., & Ashby, R. (2025). Methylphenidate Inhibits the Development of Myopia by Altering Dopamine and Norepinephrine Reuptake. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.12.52
Vancouver
Karouta C, Thomson K, Morgan I, Booth L, Ashby R. Methylphenidate Inhibits the Development of Myopia by Altering Dopamine and Norepinephrine Reuptake. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.12.52
BibTeX
@article{Karouta2025,
author = {Karouta, Cindy and Thomson, Kate and Morgan, Ian and Booth, Lauren and Ashby, Regan},
title = {Methylphenidate Inhibits the Development of Myopia by Altering Dopamine and Norepinephrine Reuptake},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.12.52}
}
EUVIMED